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Abstract
The reconstitution of a fully organized and functional 
hair follicle from dissociated cells propagated under 
defined tissue culture conditions is a challenge still 
pending in tissue engineering. The loss of hair follicles 
caused by injuries or pathologies such as alopecia not 
only affects the patients’ psychological well-being, but 
also endangers certain inherent functions of the skin. It 
is then of great interest to find different strategies aiming 
to regenerate or neogenerate the hair follicle under 
conditions proper of an adult individual. Based upon 
current knowledge on the epithelial and dermal cells and 
their interactions during the embryonic hair generation 
and adult hair cycling, many researchers have tried to 
obtain mature hair follicles using different strategies and 
approaches depending on the causes of hair loss. This 
review summarizes current advances in the different 
experimental strategies to regenerate or neogenerate hair 
follicles, with emphasis on those involving neogenesis 
of hair follicles in adult individuals using isolated cells 
and tissue engineering. Most of these experiments were 
performed using rodent cells, particularly from embryonic 
or newborn origin. However, no successful strategy to 
generate human hair follicles from adult cells has yet 
been reported. This review identifies several issues that 
should be considered to achieve this objective. Perhaps 
the most important challenge is to provide three-
dimensional culture conditions mimicking the structure of 
living tissue. Improving culture conditions that allow the 
expansion of specific cells while protecting their inductive 
properties, as well as methods for selecting populations 
of epithelial stem cells, should give us the necessary tools 
to overcome the difficulties that constrain human hair 
follicle neogenesis. An analysis of patent trends shows 
that the number of patent applications aimed at hair 
follicle regeneration and neogenesis has been increasing 
during the last decade. This field is attractive not only to 
academic researchers but also to the companies that own 
almost half of the patents in this field.
Key words: Adult stem cells; Skin grafts; Epidermis; 
Multipotential differentiation; Tissue regeneration; 
Dermal papilla; Epithelial-mesenchymal interactions
© The Author(s) 2015. Published by Baishideng Publishing 
Group Inc. All rights reserved.
711 May 26, 2015|Volume 7|Issue 4|WJSC|www.wjgnet.com
REVIEW
Submit a Manuscript: http://www.wjgnet.com/esps/
Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx
DOI: 10.4252/wjsc.v7.i4.711
World J Stem Cells  2015 May 26; 7(4): 711-727
ISSN 1948-0210 (online)
© 2015 Baishideng Publishing Group Inc. All rights reserved.
Epidermal stem cells and skin tissue engineering in hair 
follicle regeneration
María Eugenia Balañá, Hernán Eduardo Charreau, Gustavo José Leirós
Core tip: Loss of hair follicles caused by injuries or 
pathologies affects the patients’ psychological well-being 
and endangers inherent functions of the skin. Different 
experimental strategies and approaches to obtain 
mature hair follicles have been designed based upon 
current knowledge of the epithelial and dermal cells 
involved in embryonic hair generation and adult hair 
cycling, and in the epithelial-mesenchymal interactions 
among them. This review summarizes the current 
advances in hair follicle neogenesis and regeneration, 
with emphasis on those involving neogenesis of hair 
follicles in adults from isolated cells and tissue engineering 
as well as an analysis on patent trends in this field.
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INTRODUCTION 
Regenerative medicine aims to create living, functional 
tissues that repair or replace lost or damaged organ 
function resulting from disease, injury, congenital 
defects or aging. 
The main challenge of tissue engineering is the 
reconstitution of fully organized and functional organ 
systems from dissociated cells that have been propag­
ated under defined tissue culture conditions. 
Skin is the largest organ in the human body, acting 
as a barrier with protective, immunologic and sensorial 
functions. Deep skin injuries produce a complete 
destruction of skin regenerative elements. These 
wounds heal by contraction, with epithelization from 
the edges only and extensive scarring, resulting in 
reduced joint movements and cosmetic defects[1]. 
Moreover, if these lesions are too extensive, the 
healing process is unsuccessful and they become life­
threatening for the patient. Tissue engineering has 
emerged as a new interdisciplinary field combining 
scaffolds, cells and biomolecular signals towards the 
treatment of skin lesions. This useful strategy may 
contribute not only to the treatment of deep skin injuries 
but also to the understanding of skin regeneration.
The main goal of tissue­engineered skin grafts 
is to restore lost barrier function. Many dermal­
epidermal composites or skin equivalents have been 
described for use in the clinic[2] but the inability of 
these skin constructs to regenerate skin appendages 
as hair follicles has limited their use. Although the 
ability to reconstitute adult skin with functional skin 
appendages has long been a major clinical objective, 
the regeneration of epidermal appendages, such as 
hair follicles, and sebaceous and sweat glands, is a 
challenge that is still pending. 
Recent studies clearly demonstrate that there are 
multipotent stem cells with the capability to regenerate 
hair follicles and sebaceous glands in adult mammalian 
skin and this multipotency can be maintained in cell 
culture[3,4]. The hair­differentiation potentiality of 
epidermal stem cells can be activated by inductive 
dermal cells. As will be extensively reviewed in this 
article, co­grafting of those cellular components 
from mice allows complete hair reconstitution[5]. 
The successful regeneration of hair follicles in immu­
nodeficient mice suggests that creating human hair 
follicles in tissue­engineered skin grafts is feasible. 
However, regeneration of human hair in a similar 
manner has not been reported.
Skin appendages cannot be restored in healed 
wounds by current tissue­engineered skin grafts[6] 
mainly because of their limited self­regeneration 
capability in adults[7], the lack of appendage structures 
in the human skin grafts and probably an improper 
molecular microenvironment. Many strategies still need 
to be explored, particularly enriching isolated cells 
with trichogenic capability, maintaining this capability 
during processing, and providing the cells with proper 
environmental signals.
The lack of skin appendages by skin wounds and 
by pathologies such as different kinds of alopecia not 
only affects the patients’ psychological well­being[8], 
but also endangers the inherent functions of the skin. 
Skin appendages cannot regenerate on their own 
after damage[7]. For the fully functional regeneration 
of ectodermal organs, it has been proposed that a 
bioengineered organ could be developed by reproducing 
the embryonic processes of organogenesis. 
This review summarizes current advances in the 
different experimental strategies to regenerate or 
neogenerate hair follicles, in vitro and in vivo, with 
emphasis on approaches that include the neogenesis 
of hair follicles in adults from isolated cells and by 
tissue engineering as well as an analysis on patent 
trends in this field.
ANATOMY AND BIOLOGY OF HAIR 
FOLLICLES
The skin consists of three layers: epidermis, dermis, 
and hypodermis. The epidermis is in fact a multi­
layered epithelium extending from the basement 
membrane that separates it from the dermis to the 
air. The dermis is located below the epidermis and 
is a connective tissue comprised of extracellular 
matrix, fibroblasts, vascular endothelial cells, and skin 
appendages.
Skin appendages, including hair follicles, sebaceous 
glands and sweat glands, are linked to the epidermis 
but project deep into the dermal layer. A human has 
around five million hair follicles with two types of hair, 
terminal hair (long, thick pigmented) and vellus hair 
(thin, unpigmented)[9]. 
Hair follicles are composed of an outer root sheath 
Balañá ME et al . Hair follicle neogenesis and regeneration
712 May 26, 2015|Volume 7|Issue 4|WJSC|www.wjgnet.com
(ORS) that is contiguous with the epidermis, an inner 
root sheath (IRS) and the hair shaft (HS). The matrix 
surrounding the dermal papilla (DP), in the hair root, 
contains actively dividing and relatively undifferentiated 
cells that are essential for follicle formation. 
In embryogenesis, the skin begins as a single layer 
of epidermal stem cells. Then, mesenchymal cells 
populate the skin to form the underlying collagenous 
dermis[10]. Human hair follicles start to develop through 
complex morphogenetic processes resulting from 
highly coordinated series of bidirectional epithelial­
mesenchymal interactions[11]. Hair follicle development 
is initiated by the appearance of a thickening in the 
embryonic ectoderm called placode resulting from 
the condensation of the underlying mesoderm that 
will form the DP[12]. The DP becomes a permanent 
part of the follicle base[13] enveloped by the hair bulb. 
It is considered the commander of the hair follicle 
determining the hair thickness, length, and life cycle[8]. 
Signals from the condensed mesoderm induce the 
proliferation of the placode which forms mature hair 
follicles by a systematic series of differentiation and 
proliferation processes of epithelial cells. The hair 
follicle becomes fully mature when its bulb nears the 
bottom of the dermis. At this point, the proliferative 
cells (matrix) at the follicle base continue to divide, 
producing progeny cells that terminally differentiate 
to form the growing hair that emerges from the skin 
surface. The inner layers begin to differentiate into 
concentric cylinders to form the central HS and the 
surrounding channel, the IRS.
These tissues undergo continual rejuvenation 
and, in response to injury, they must be prepared for 
wound repair. The capability of the skin for maintaining 
tissue homeostasis, regenerating hair, and repairing 
the epidermis after injury resides in its stem cells. 
HAIR FOLLICLE STEM CELLS AND THE 
HAIR CYCLE 
Stem cells are undifferentiated cells that are ultimately 
responsible for the constant renewal of the skin due 
to their distinguishing properties of self­renewal for 
the entire life span of an organism and their ability to 
differentiate into a variety of specialized cells.
A pool of progenitor cells is located on the base­
ment membrane of the skin. These cells contribute to 
epidermal homeostasis undergoing continuous self­
renewal and differentiation to keratinocytes that migrate 
towards the surface of the skin where they undergo 
terminal differentiation and maturation providing the 
skin’s barrier properties. 
Another reservoir of slow­cycling multipotent stem 
cells that gives rise to a range of differentiated cell 
types in skin is located in a specialized region of the 
ORS in the hair follicle, known as the bulge[3,4,14­16]. 
Early work showed that these slow cycling multipotent 
stem cells not only contribute to the growth of hair 
follicles themselves and of the sebaceous glands[3] 
but also can be activated and migrate out of hair 
follicles in order to repair the damaged epithelium[17]; 
however, they contribute little to the turnover of the 
intact epidermis. In the absence of these hair follicle 
stem cells (HFSC), hair follicle and sebaceous gland 
morphogenesis is blocked, and epidermal wound 
repair is compromised[18]. The epithelial­mesenchymal 
interactions with the underlying DP play a pivotal role 
in embryonic hair genesis[12], in the regulation of post­
natal hair follicle cyclical activity, and  in the repair of 
wounded skin[19­22].
Unlike most organs, hair follicles do not reach 
homeostasis once they mature. Each mature hair 
follicle is a regenerating system, which physiologically 
undergoes cycles of growth (anagen), regression 
(catagen), and rest (telogen) numerous times in adult 
life[23].  In catagen, hair follicle stem cells are maintained 
in the bulge. Then, the resting follicle re­enters anagen 
(regeneration) when proper molecular signals are 
provided. During late telogen to early anagen transition, 
signals from the DP stimulate the hair germ and 
quiescent bulge stem cells to become activated[24]. 
Many paracrine factors are involved in this crosstalk at 
different hair cycle stages and some signaling pathways 
have been implicated[3,19,25]. In anagen, stem cells in 
the bulge give rise to hair germs, then the transient 
amplifying cells in the matrix of the new follicle proli­
ferate rapidly to form a new hair filament[26].
Even if it is generally believed that hair follicles do 
not form after birth in humans[27], the formation of 
vellus hair follicles from the reconstituted epidermis 
of an abraded area of facial skin was described in 
1956[28]. However, the great challenge of skin tissue 
engineering and skin wound regeneration remains to 
be its inability to reliably reconstitute skin appendages, 
most notably hair follicles and sweat glands. The 
information about the mechanisms that generate and 
maintain skin appendages provided by recent studies 
with skin­derived progenitor cells, may be the basis 
of new therapies that could help to overcome these 
limitations.
CAUSES OF HAIR LOSS AND 
REGENERATION OF THE HAIR FOLLICLE
Hair loss responds to different causes ranging from 
mild traumas, such as hair fiber plucking, to severe 
traumas such as partial­ or full­thickness skin lesions. 
Pathological processes, such as cicatricial or non 
cicatricial alopecia, can also be responsible for hair 
loss. After plucking, if HFSC and DP remain, a new 
hair filament would be spontaneously regenerated. 
Some label retaining studies have shown that hair 
follicle stem cells in the bulge remain intact after hair 
plucking[29,30] whereas others reported bulge stem cells 
suffering apoptosis after plucking which are replaced 
by label retaining cells coming from hair germ[31]. 
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inhibition of the canonical Wnt signaling system in 
androgen sensitive DPCs. We provided evidence that 
androgen activation of GSK­3β would be responsible 
for the inhibition of Wnt/β­catenin signaling[40]. The 
current pharmacological treatment for AGA includes 
androgen metabolism modulators, such as the 5­alpha 
reductase inhibitor finasteride and the antiandrogen 
agent flutamide. Nevertheless, the results of these 
treatments are not only variable and patient­dependent, 
but can also cause undesirable side effects. Therefore, 
therapies acting on specific molecular targets are 
necessary to treat this pathology downstream from the 
actual antiandrogenetic pharmaceutical modulators. 
The crosstalk between the androgen receptor (AR) 
and Wnt/β­catenin signaling pathways could be one 
alternative therapeutic target, among many others 
recently reviewed[41]. 
In these experimental approaches, modulation of 
the intra­follicular microenvironment and the extra­
follicular macroenvironment could contribute to promote 
growth of the existing hair follicles but not to increase 
their number by the formation of new ones. 
Regeneration of hair follicles by recombination of hair-
follicle parts
Taking into account the inductive ability of DP and 
the current knowledge on epithelial­mesenchymal 
interactions, different recombination of dermal and 
epidermal tissue have been employed for hair follicle 
regeneration. In the early 1960s, researchers showed 
that whole follicle end bulbs and isolated whole whisker 
papillae (containing dermal and epidermal components) 
remain viable and may produce whisker hair follicles 
in a new site[42]. The most surprising finding was that 
isolated DPs (without epidermal components) were 
capable of inducing the generation of new hair follicles 
recruiting epithelial cells from the implantation sites. 
The same results were obtained when epidermis 
from different origins were transplanted together 
with whisker DP[43]. Regeneration of hair follicles was 
also observed in both mice[43­45] and humans[46] when 
dermal sheath tissue was used, which was sufficient to 
regenerate also the DP structure. After implantation, 
the whisker DP was capable of inducing  hair follicle 
regeneration retaining  the information to determine 
hair fiber type and follicle size[47].
Neogenesis of hair follicles in adult individuals from 
isolated cells
Grafting of dermal­inductive tissue is limited by the 
fact that it is not possible to generate more hair follicles 
than the obtained from the donor tissues. To overcome 
this limitation different approaches and experimental 
models using freshly or cultured isolated cells from 
both dermal and dermal/epidermal origin were tested. 
Most of them involved neonatal and embryonic murine 
cells. One of the first models used was the chamber 
assay (Figure 1) in which dermal and epithelial cells 
are seeded inside a chamber consisting of a cylinder 
It was also observed that the slow­cycling bulge 
cells (CD34 positive cells in mouse) are involved in 
normal hair homeostasis and wound healing, whereas 
regeneration after hair plucking involved actively 
cycling cells from the lower ORS[26]. However, the 
cell dynamics in this process is less clear than in the 
physiological renewal and further studies are required 
to understand this process.
However, when the cellular niches are completely 
lost, it is necessary to generate a completely new hair 
follicle in a process called hair follicle neogenesis.  
Based on the knowledge on the epithelial and dermal 
cells, and their interactions, during the embryonic hair 
generation and adult hair cycling, different experimental 
approaches have been designed to regenerate hair 
follicles or generate new ones by the neogenesis 
process. 
These hair regeneration and neogenesis attempts 
are recapitulated in this article, and can be classified into 
4 categories: (1) reversion of pathological intra­ and/or 
extra­follicular environment, for instance androgenetic 
alopecia (AGA); (2) regeneration of complete hair 
follicles from the recombination of hair follicle parts; (3) 
neogenesis of hair follicles from isolated cells; and (4) 
neogenesis of hair follicles by tissue engineering.  
Reversion of pathological intra- and/or extra-follicular 
environment
Hair follicle cycle and growth can be affected and 
deregulated by paracrine factors from the follicle itself 
and/or from the surrounding dermal tissue, or by 
endocrine factors[32,33] leading to hair loss. Many factors 
have been described as molecular mediators of hair 
follicle growth [11]. Some of them, such as PDGF[33] and 
Wnt proteins[34], are positive regulators while others, 
such as BMPs[35], suppress hair growth. Many paracrine 
factors involved in the epithelial­mesenchymal crosstalk 
at different stages of the hair cycle, and some implicated 
signaling pathways, have also been studied[3,19,25]. 
In addition, endocrine factors, such as sexual 
hormones, have both physiological and pathological 
effects on hair growth as in human male beard, and 
androgenetic alopecia respectively. Androgenetic 
alopecia[36] is a common, progressive disorder in which 
large, terminal scalp hairs are gradually replaced by 
smaller hairs following a defined pattern. The DP is 
the site through which androgens act on follicle cells 
by altering the regulatory paracrine factors involved in 
the differentiation and proliferation of HF stem cells. 
DPs from balding scalp have higher levels of androgen 
receptor and 5­alpha reductase. Dihydrotestosterone 
can induce DP to secrete factors including, TGF­
beta1 and DKK­1 which down regulate keratinocytes 
growth[37,38].
A functional crosstalk between the androgen 
receptor and Wnt signaling pathways in DPCs has been 
described in target tissues[39]. Moreover, our group has 
demonstrated that androgens regulate secreted factors 
involved in normal HF stem cell differentiation via the 
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inserted through a full­thickness skin lesion in mouse 
dorsal skin, covered by a dome. In former studies 
using this device in nude mice[48], it was showed  that 
hair buds obtained from neonatal mice combined with 
fresh neonatal dermal cells or with immortalized clones 
from vibrissae rat DPCs produced mature and cycling 
hair follicles. Using the same chamber assay, hair bud 
preparations without any additional inductive dermal 
component were unable to form hair follicles resulting 
in a scarring reparative tissue, a thin epidermis and 
a dermis without appendages[49]. On the other hand, 
the combination of hair buds with fresh dermal cell 
preparations or early passages of cloned vibrissae 
cell lines resulted in skin with normal epidermal and 
dermal layers.
Although these studies confirmed the trichogenic 
potential of dissociated dermal cells, particularly DPCs, 
the conditions of the chamber assay correspond to 
a wound healing environment and do not represent 
the physiological status. Other approaches allow 
studying the trichogenic potential of isolated cells 
in a more physiological environment, as is the case 
of the patch assay (Figure 1). This assay consists 
in injecting dissociated murine neonatal epidermal 
and dermal cells hypodermically into adult mouse 
skin. This system, originally described by Zheng 
et al[50], showed the formation of cell clusters that 
resulted in “infundibular cysts” which generated hair 
germs, followed by pegs that grew to differentiate 
into cycling mature pilosebaceous units. Surprisingly, 
whereas patch hair follicles were in anagen phase, 
the host skin hair follicles were in telogen and vice 
versa, suggesting that follicle cycling depends on the 
trichogenic cells and not on the host skin hair cycling. 
Even when the shaft grows inside an intradermal cyst 
that tends to extinction by inflammatory processes, 
none of the other already described systems at that 
moment showed to be so efficient to evaluate the 
trichogenic potential of isolated cells. A variation of this 
method is called tracheal grafting method. It consists 
in inoculating rat tracheas with fresh or cultured 
keratinocytes from newborn mice together with 
newborn fibroblasts or cultured DPCs and implanting 
them subcutaneously in athymic mice for four weeks. 
In this assay hair follicles and sebaceous glands were 
generated using cultured keratinocytes from newborn 
mice and fresh newborn fibroblasts[51]. Although 
adult mice keratinocytes successfully produced  a two 
layered epithelium, they failed to generate hair follicles 
or sebaceous glands[51]. 
Other strategy to evaluate the hair inductive capa­
bility of dermal cells is the “flap assay” (Figure 1). This 
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Cell sources
Mature 
hair follicle
Embryonic hair bud
 (A) Fresh cells or monolayer-cell culture
Inductive dermal cells 
or DPCs or DSCs
Epithelial cells 
or HFSC
(B) 3D-cell culture
Homotypic 
DPC spheroids
Heterotypic 
DPC-epithelial spheroids
Hair germs Scaffold with DPCs 
and epithelial cells
(C) Bioengineered 
composite skin
(D) Trichogenic assays
 Chamber assay
Patch assay
Flap assay
Bioengineered composite 
skin grafting
Hair follicle neogenesis 
in skin-grafted area
(E) Grafting in 
athimyc mice
Figure 1  Hair follicle neogenesis using isolated epithelial and dermal cells. Inductive-dermal and Epithelial Cells can be obtained from adult tissue or embryonic 
sources. Isolated cells by enzymatic digestion of living tissues, or monolayer cell cultures (A) can be used in the trichogenic assays (D): Chamber assay; Patch assay; and 
flap assay. Moreover, isolated cells can be cultured in 3D-conditions, allowing them to create their own extracellular matrix as in the case of homotypic and heterotypic 
spheroids and hair germs (B). Also, cells can be seeded on a precast scaffold used for cellular support or used to produce a bioengineered composite skin (C). Any 
of these constructs can be evaluated by the trichogenic assays (D): Flap assay; and Bioengineered composite skin grafting. All these trichogenic assays are mainly 
performed in the back-skin of athymic mice in order to avoid immune rejections and to take advantage of its bare-skin (E). DPCs: Dermal papilla cells; DSCs: Dermal 
sheath cells; HFSC: Hair follicle stem cells. 
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approach originally described by Qiao et al[52] consists 
in: (1) generating a skin flap in the dorsal skin of nude 
mice; (2) locating an embryonic epidermis supported 
by a silicone sheet in direct contact with the muscle 
with the basal side of the embryonic epidermis facing 
upwards; (3) seeding embryonic murine dermal cells 
or cultured DPCs onto the basal face of the graft­
epidermis; and (4) pulling over the graft and suturing 
the flap edges. In this configuration the graft­dermal 
cells were layered between the graft­epidermis and the 
host connective tissue. When fresh embryonic dermal 
cells were used, abundant hair was developed four 
weeks after grafting. The induced hairs were oriented 
vertically down towards the silicone sheet. After surgical 
flap inversion, the formed hairs were exposed in the 
host skin surface and survived for more than 12 mo.
Neogenesis of hair follicles by tissue engineering
Although the assays described above provided much 
information respect to the hair neogenesis process 
and the cells involved in it, the high number of cells 
required, the need of in vivo animal models and the 
poor results obtained with human cellular sources 
make these procedures not applicable for clinical uses 
in the near future. The development of new strategies 
has become necessary and begun to emerge. They 
are mainly focused on tissue engineering­based follicle 
neogenesis, including three­dimensional (3D) cell 
culture conditions generated by the cells themselves or 
by the use of biocompatible scaffolds. 
Lee et al[53] developed a simplified procedure to 
reconstitute hair­producing skin. They obtained both 
epidermal and dermal cells from newborn mice, and 
mixed them in different ratios. A high density cellular 
suspension was prepared in drops of minimal volume 
on tissue culture inserts or wells. They allowed the 
cells to settle until gel consistency was obtained. 
Alternatively, they seeded the cells on the collagen­
side of the IntegraTM matrix (porous matrix of cross­
linked bovine tendon collagen and glycosaminoglycan 
and a silicone layer). Both constructs were grafted 
in full thickness skin wounds generated on the back 
of athymic mice. After grafting, the epidermal cells 
formed a basal layer and some epidermal microcysts 
could be observed. Dermal cells started to form dermal 
condensations adjacent to the epidermal layer or cysts. 
Eight days after grafting hair germ started to appear 
and progressed to hair peg, observing complete 
hair follicles four days later that kept the ability to 
continuously cycle for at least one year. This method 
would allow preparing constructs with specific sizes 
and shapes useful to treat alopecia by tissue implants.  
Two separate reports[54,55] showed hair follicle 
neogenesis using hair germs obtained by the previously 
described “organ germ method”[56]. One of them[54] 
generated bioengineered hair germs mixing epithelial 
and mesenchymal cells derived from mouse embryos 
within a collagen gel drop. In these culture conditions, 
the two cellular types generated a structure with 
two cellular layers separated by a translucent region 
they called hair germ. When these hair germs were 
transplanted ectopically into subrenal capsules, the 
presence of mature hair follicles was observed. These 
bioengineered hair follicles had a normal histological 
structure with the concentric epithelial layers of ORS 
and IRS, DP, hair matrix, and sebaceous glands. These 
follicular units transplanted intracutaneously in nude 
mice (Figure 1), were connected to the arrector pili 
muscle and nerve fibers and were able to produce hair 
shafts and cycling.
In addition, a fully functional orthotopic hair re­
generation was demonstrated via intracutaneous 
transplantation of bioengineered hair follicle germs 
generated by epithelial and mesenchymal cells derived 
from mouse embryos[55] (Figure 1). These bioengineered 
hairs responded to hair cycles and had the correct 
structure of natural hair follicles and shafts, and the 
proper connections with surrounding host tissues. Qiao 
et al[57], using embryonic dermal cells and hair­peg­
derived keratinocytes, generated cellular aggregates by 
hanging drop methods. These aggregates cultured in 
methylcellulose coated wells elongated, and after seven 
days, acquired hair follicle features. These structures 
termed “proto hairs”, showed a morphological structure 
more developed respect the previously described “hair 
germs”[54,55]. They presented hair­like characteristics 
as an inner mass of cells similar to the DP structure 
surrounded by matrix­like keratinocytes and a partially 
keratinized substance that could represent intent to 
produce a hair shaft. After implantation into shallow 
incisions in nude mice (Figure 1), black­pigmented hair 
fibers were observed emerging from epidermis. These 
hairs persisted throughout the experimental period (6 
mo) and were shown to regrow after plucking.
Although embryonic tissues are used as cellular 
sources, these studies showed the potentiality of 
dissociated cells to form hair follicle germs or proto­
hairs able to generate mature hair follicles both by 
ectopic and orthotopic implantation. Collectively, 
these studies provide a proof of concept for the use of 
Follicular Cell Implantation to restore hair in patients 
suffering from hair loss.
As it was already mentioned, dermal cellular com­
ponents from the skin, such as DPCs or dermal sheath 
cells (DSCs), have the potential to induce hair formation 
in in vivo assays and also induce in vitro differentiation 
of hair follicle stem cells to hair lineage[25,40]. Even if it is 
possible to isolate and culture DPCs, the inductive ability 
tends to fade with time in 2D cultures[6,58]. Considering 
that the hair follicle neogenesis requires a large number 
of DPCs, it is necessary to look for new strategies to 
maintain their inductive potential in culture in order 
to use them in skin bioengineering and hair follicle 
neogenesis.
The niche generated by the extracellular matrix 
(ECM) of DP probably plays a key role in keeping 
DPC inductive activity. Accordingly, the loss of ECM 
throughout culture time could be responsible for the 
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fading of DPC inductive properties. 
DPCs are naturally aggregated at the hair­bulb 
base. In proper culture conditions, these cells tend to 
aggregate[13,59] and their inductive activity is preserved 
after they are grafted in this state. It has been demon­
strated that it is possible to generate dermal papilla 
spheroidal microtissues using different methods 
including rotation, two-step rotation and flotation, and 
hanging drop[60­62]. Osada et al[63] artificially prepared 
DPC spheres by aggregation of mouse vibrissae 
follicle DPCs in a round­bottom 96­well low­binding 
plate. These spheres expressed higher amounts of 
versican, an indicator of inductive capability, than 
DPCs in monolayer cultures. In a “patch assay” (Figure 
1), together with embryonic­epidermal cells, they 
induced hair follicle neogenesis, keeping their inductive 
capability for at least twenty­six passages.
However, these methods are labor intensive and 
the microtissues obtained have a very variable size 
and cell number content, which reduces reproducibility.
DPCs can self­assemble into dense spheroids when 
seeded on controlled biomaterial surfaces such as 
poly (ethylene­co­vinyl alcohol) (EVAL)[64] or polyvinyl 
alcohol (PVA) membranes[65]. The DPC microtissues 
generated on EVAL surface[64] expressed DPC­markers 
such as neural cell adhesion molecule (NCAM)[66] 
and α-smooth muscle actin[67]. Alkaline phosphatase 
activity, which correlates with hair follicle inductive 
ability of DPC[68], was higher in spheroid microtissues 
than in monolayer cultured cells. Finally, the spheroids 
mixed with newborn mouse epidermal cells and 
injected into the hypodermis of nude mice in a “patch 
assay” (Figure 1) were able to generate new hair 
follicles. 
The use of PVA as substratum material enhanced 
DPC aggregation[65], preventing cellular attachment 
and spreading. Using this material and reducing 
culture surface it is possible to control the number, 
size and compaction of spheroidal microtissues. DPCs 
quickly aggregated into a single spheroid whose 
diameter decreased progressively due to tissue 
compaction. The expression of DPC­inductive capability 
markers, versican[69] and alkaline phosphatase[68], 
were present in spheroids of various sizes. All these 
experiments were made both with adult DPCs from 
rat vibrissae, and human scalp hairs, giving similar 
results. The hypodermal injection in nude mice of 
eighty spheroids altogether with keratinocytes from 
newborn mice induced HF neogenesis. These results 
are very promising given that transplantation of 
dispersed cultured human DPCs had shown very low 
efficiency in inducing new hair follicles[70]. Using the 
same approach, heterotypic folliculoid microtissues 
or hair follicle­like organ germs were produced using 
dissociated adult epithelial and mesenchymal cells by 
self­assembly on EVAL coated wells[71]. Keratinocytes 
and DPCs seeded together grew into floating or 
loosely attached multicellular spheroids. Histological 
analysis showed that the spheroids are composed by 
a core of DPCs surrounded by keratinocytes. These 
keratinocytes expressed keratin 6, a cytokeratin 
preferentially expressed by ORS in vivo[72], and DPCs 
expressed versican, a marker associated to HF­
inductive ability. Using “patch assays” (Figure 1) 
disperse DPCs and keratinocytes did not form new hair 
follicles, whereas heterotypic folliculoid microtissues 
did. These last experiments would contribute to the 
development of new strategies for scalable production 
of organoid microtissues of epithelial organs for hair 
follicle neogenesis by bioengineering approaches.
Altogether, these results strongly indicate that the 
hair­inductive capability of DPCs can be restored by 
three­dimensional spheroid cultures. 
Hair follicle neogenesis using human cells
During embryogenesis, dermal mesenchymal cells 
drive HF development and a condensate of these 
cells remains during adult life forming hair follicle 
DP. These cells retain the capability to induce hair 
follicle regeneration and neogenesis[21,73] as reviewed 
by Ohyama et al[5] and Yang et al[6]. However, most 
of these experiments were performed using murine 
and embryonic cells, whereas DPC from human 
origin showed many difficulties to maintain inductive 
capability in culture[74]. 
As discussed above, rat cultured DPCs self­aggregate 
within the dermis forming a papilla­like structure that 
synthesizes its own extracellular matrix[13]. However, 
such behavior was not observed with cultured human 
DPCs, highlighting specie-specific differences. Human 
keratinocytes from ORS and DPCs cultured in MatrigelTM 
(3D network of extracellular matrix proteins and 
collagen) have shown to form tubule­like structures in 
this skin­equivalent in vitro[75] and organize themselves 
into epidermoid cyst­like spheroids[72,76], but did not 
form complete hair follicles. Similarly, Sriwiriyanont 
et al[77], observed neofollicle formation in nude mice 
grafted with engineered skin substitutes containing 
murine DPC and human keratinocytes in a collagen­
glycosaminoglycan matrix, but not in those containing 
human DPC and human keratinocytes.
Ehama et al[78] reported the formation of hair 
follicle­like structures using human primary cultures of 
foreskin­ or adult­derived epidermal cells co­grafted 
with murine DPCs by a chamber assay (Figure 1). 
The innermost regions were similar to the hair cortex 
and medulla of mature human follicles. Hair shaft­like 
fibers occasionally emerged at the skin surface, and 
structures, reminiscent of the DP, at the follicle bottom 
were also observed. However, these structures showed 
no bulge region, nor all the follicular epithelial layers, 
and the DP­like tissue failed to express the anagen 
DP marker versican. These hair follicle­like structures 
correspond to the initial follicle formation suggesting 
that the differentiation process was altered.
Using the “flap assay”[52] (Figure 1), Qiao et al[79] 
showed that DPCs from human scalp combined with 
epidermis from mouse embryo produced mature 
717 May 26, 2015|Volume 7|Issue 4|WJSC|www.wjgnet.com
Balañá ME et al . Hair follicle neogenesis and regeneration
hair follicles that persisted and grew. The authors 
reported that the inductive potential of DPCs could be 
maintained using keratinocyte­conditioned medium. 
These DPCs were able to form DP and dermal sheath 
in vivo. 
Spheroids microtissues were also obtaining by 
culturing human DPCs in a 96­well low­binding plate, 
and implanted intradermically into nude mice using 
the “patch assay” (Figure 1)[80]. This combination of 
human DPC spheres with murine neonatal epidermal 
cells generated new hair follicles. In contrast, hair 
follicles were never observed when monolayer DPC 
cultures were used.
Cultured human DPCs do not induce hair neo­
genesis unless changes in the culture conditions are 
made. In this sense, the formation of DPC­microsphere 
tissues has shown to improve hair­inductive properties 
of rodent cells as well as the expression of cell­markers 
associated with these properties[63­65]. Therefore, 
all these observations encouraged investigators to 
look for new strategies intended to achieve the first 
step toward human hair follicle neogenesis that is, 
providing culture conditions that confer hair­inductive 
ability to human DPCs. Higgins et al[74] evaluated the 
human DPC­transcriptome observing that monolayer 
DPC cultures showed the most important changes 
immediately after early outgrowths from DP explants. 
These changes involved 3729 transcripts, including 
several involved in hair follicle development. This large 
number of differentially expressed transcripts shows 
the physiological changes that 2D culture conditions do 
on the molecular signature of DPCs. The generation of 
DPC spheroids by the hanging drop method partially 
restores the intact DP signature. These human­DPC 
spheres induced hair follicle neogenesis when placed 
in between foreskin epidermis and dermis and grafted 
onto nude mice (Figure 1). These hair follicles showed 
a DP and dermal sheath highly positive for alkaline 
phosphatase, hair specific keratin markers disposed in 
concentric layers and blood vessel formation around 
follicles. Nevertheless, neither sebaceous glands nor 
hair fibers emerging from the skin surface were seen. 
These results suggested that human DPC spheroids 
would be able to initiate hair follicle morphogenesis 
but the production of a complete hair follicle requires 
additional signals. 
Recently, Miao et al[81] produced DPC­spheroids from 
cultured DPCs on a MatrigelTM scaffold. As reported by 
Higgins et al[74], the DPC spheres were shown to restore 
DP­signature gene expression of NCAM, versican and 
α-smooth muscle actin (α-SMA), lost during monolayer 
culture. The authors also claimed that these DPC­
spheres, combined with hair germinal matrix cells, onto 
Matrigel­coated plates produced colorless fiber­like 
structures in vitro. 
Other alternative to culture dermal mesenchymal 
cells in 3D conditions is the organotypic method con­
sisting in culturing cells inside a scaffold. Using this 
method, Wu et al[82] prepared a collagen gel with 
human DPCs or dermal sheath cells (DSCs). This gel 
was seeded with keratinocytes from interfollicular 
skin, superior ORS or inferior ORS obtaining in vitro 
a bilayered skin. Nonetheless, only the constructs 
containing superior ORS keratinocytes showed hair 
follicle­like structures. That is, an outer root sheath, 
nearly ten layers of concentric epithelial cells, a middle 
layer IRS­like and some keratinoid substances in the 
center, similar to a hair fiber. When these constructs 
were transplanted into nude mice (Figure 1), only 
the organotypic cultured tissue containing superior 
ORS keratinocytes and DPCs exhibited hair follicle 
structures.
In a recent study[83], composite skin substitutes 
were generated by seeding human neonatal foreskin 
keratinocytes onto a dermal equivalent structure 
cultured in air­liquid interface condition. This dermal 
equivalent was composed of DPCs from human scalp 
contained in a collagen­I gel. Eight weeks after grafted 
onto nude mice (Figure 1), these constructs presented 
hair follicles showing bulb, dermal sheath, hair matrix 
and cortex. Histological analysis showed concentric 
layers of IRS and ORS, sebaceous glands and hair 
shaft. Inmuno­histochemistry assays revealed that 
both epithelial and dermal cells from neo­follicles 
were from human origin, and that DPCs and DSCs 
expressed human nestin and versican.
The analysis of all these reports leads to the 
conclusion that hair follicle neogenesis using human 
epithelial and dermal cells is a very difficult task that 
requires special culture conditions, somehow recreating 
the normal or embryonic skin environment, and the 
use of embryonic or neonatal cells.
Very recently, we prepared in our laboratory a 
dermal­epidermal skin substitute by seeding an 
acellular dermal matrix with cultured hair follicle 
epithelial stem cells and DPCs, both obtained from 
adult human scalp[84]. These constructs were grafted 
into a full­thickness wound generated on nude mice 
skin (Figure 1). In only fourteen days, histological 
structures reminiscent of many different stages of 
embryonic hair follicle development were observed in 
the grafted area. These structures showed concentric 
cellular layers of human origin, and expressed k6hf, 
a keratin present in epithelial cells of the companion 
layer. Although the presence of fully mature hair 
follicles was not observed, these results represent, 
up to our knowledge, the first report showing that 
both epithelial and dermal cultured cells from adult 
human scalp in a dermal scaffold were able to produce 
in vivo structures that recapitulate embryonic hair 
development.
ANALYSIS OF PATENTS TRENDS IN 
HAIR FOLLICLE REGENERATION AND 
NEOGENESIS
So far, we have made a concise review of the scientific 
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literature describing the attempts to regenerate 
the hair follicle. We have also mentioned a number 
of reviews on academic articles dealing with hair 
regeneration or wound induced follicle neogenesis 
that have been published in recent years[85]. However, 
reviews on tissue engineering and hair regeneration 
patents are less common. Many of these strategies 
have been combined in different methods intended for 
use in active applications. In this section, we review and 
analyze published patents on hair regeneration[86­150], as 
a measure of the interest in the industry for this area 
of research, identifying the currently available technical 
developments, favorite research strategies and main 
points of interest. Parameters analyzed include not 
only chronological patent publishing trends, but also 
the most cited patents, top patent owners (assignees), 
most cited documents, and the classification of patents 
among technology areas according to the International 
Patent Classification (IPC). Moreover, hair regeneration 
applications that have been patented throughout the 
years are screened (Figure 2). 
Patent search was performed using the Thomson 
Innovation Database, a collaboaration platform for 
searching and analyzing global patents, integrated 
with analytics and workflow tools which allow access 
to more than 40 databases from different countries. 
For each particular group of hair regeneration, specific 
keywords (descriptors) were selected. Descriptors 
were chosen based on the synergy of two approaches: 
the search of specific keywords and concepts used in 
academic publications, and the selection of additional 
descriptors from specific patent vocabulary. Therefore, 
the keywords are: Stem cell; progenitor cell; precursor 
cell; repair; growth; wound; regeneration; neogenesis; 
skin; tissue engineering; dermis; epidermis; dermal; 
hair follicle; sebaceous gland and sebaceous unit. The 
presence of the chosen descriptors was checked in the 
title, abstract and claims of existing patents, considering 
documents published between years 1990 and 
2014. More than forty technology patent and patent 
application databases were used for patent search, 
including the Spanish OEPM, the American USPTO, the 
worldwide WIPO, the European EPO, the patent offices 
of France, Germany, Great Britain and the Far­Eastern 
patent offices of Japan, China and South Korea. Besides 
the keywords, the search process was completed with 
the use of the IPC codes under which the patents of 
interest could be framed. The combination of the search 
approaches previously mentioned offered a universe 
of about 475 patent families, which were manually 
reviewed and filtered, setting aside those directed to 
gene therapies, mesenchymal, embryonic stem cell, 
osteoblast, neuron and hematopoietic cell and others. 
The result of this process was the identification of 65 
patent families[86­150]. The selection of the document to 
be considered in patent trends was the first published. 
It is important to note that patent applications can be 
published in different countries under different national 
numbers. This is called the family of the patent. In 
the search performed for the present study, care was 
taken to include just one patent per family.
Tables showing patents that are most frequently 
cited take into account all the patents in the family, 
since it may occur that the earliest document is not 
necessarily the most cited one.
Competitive dynamics
The competitive dynamics indicator shows the distri­
bution of patents among the different organizations, 
providing a general picture of the tissue repair rege­
neration industry and their relative positioning. On 
the basis of this information we can identify the most 
prolific applicants for hair regeneration technology 
patents in the world, by establishing the number of 
applications filed by each company.
Table 1 lists the applicants that have filed more 
than one application, which will be our “Reference 
Group”. Most of the members of this group are manu­
facturing companies, indicating that this technology 
belongs to the industrial sector. The highest percentile 
is shared by a small number of applicants with five 
patents each, while a second group includes a wide 
range of companies with no clear technological 
leadership. 
The group of companies of the first percentile 
shown in Table 1, are the leading hair regeneration 
manufacturers Shiseido Co ltd and Aderans Research 
Institute, which own more than five published patents 
each, and which own almost 20% of all filed applications 
in this field.
The second percentile of institutions having one or 
two applications each could offer a favorable scenario 
for technology transfer.
It should be highlighted that there are over 20 
institutions or about 40% patent applications from non­
profit institutions including universities and foundations. 
The most prolific institutions are: Jilin University, 
University of Pennsylvania, University of Southern 
California and National Taiwan University, which gives 
an idea that this field is very prolific in academic 
institutions.
Technology trends
The patent technology trends indicator introduces 
the serial number of patent applications showing 
how technology has evolved over time as well as its 
appropriation by companies and non-profit institutions 
in the field of hair regeneration. This technological 
area has experienced constant growth. In the 90’s an 
average of 2.5 patent applications were filed per year, 
and in the first decade of the 21th century the average 
increased to 6 patent applications per year (Figure 2). 
The years 2011 and 2012 stand out as the ones 
with the most patent applications, 10 and 16 res­
pectively.
Aderans Corp Company filed most patent applica­
tions from 2005 to 2008. Shiseido and Follica, as well 
as the University of Pennsylvania have filed patent 
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applications in recent years. 
From this general perspective, it can be inferred 
that the technological field is, at present time, in a 
developmental stage, with an annual growth rate of 
10%, based on the number of patent documents filed 
since 2010. 
From another perspective, Figure 3 shows the 
cumulative patent families published in the last 20 
years. As it can be seen, since 2005 there has been 
a remarkable increase of attraction in the area: while 
50% of the patents required 15 years to be generated, 
the remaining 50% has been filed over the past five 
years. 
The analysis of patent application­trends shows 
that, at the present time, the development of hair 
regeneration technology is evolving positively, making 
this technological field attractive to companies that 
start producing and selling products as a result of the 
development of hair regeneration technology.
Technological leadership indicator
The technology leadership indicator identifies specific 
companies with the most consolidated and developed 
technologies in this specific field. The Patents which 
have received the highest number of citations are 
considered to have the highest degree of technological 
progress or impact. The analysis of patent citations 
allows the identification of patents which have been 
most useful for later researchers and for the deve­
lopment of newer technologies and may illustrate 
the diffusion of technical knowledge and its different 
practical applications throughout the years. 
Just as those patents that have received most 
citations are not always the most relevant ones, and 
those most relevant are not always the most cited 
ones; a number of empirical studies demonstrate a 
strong correlation between those variables. In Table 2 
the 10 most cited institutions as references are listed.
Up to the present, New York University and Pen­
nsylvania State University have received the highest 
number of citations with 29 citations which reflects the 
importance of the works of Lavker et al[86] previously 
described. Following these institutions, companies 
likse Biointegrence Co and Phoenixbio Co Inc, and 
Anticancer Inc have 17 citations. The Hospital for Sick 
Children, Aderans Research Institute Inc, Sci Torico 
Innovations Inc and Trichoscience Innovations Inc are 
among the most innovative companies.
Skin substitutes were among the earliest products 
to be developed using principles of tissue engineering, 
and their success is evident in the clinical use of 
several commercially available products. However, skin 
substitutes capable of performing all the functions of 
normal skin are not currently available, which limits 
their use in patients. Hair follicle neogenesis is not 
observed using current skin substitutes. Thus, the 
efforts in hair and skin bioengineering continue to be in 
a leading place in regenerative medicine. Furthermore, 
hair restoration is one of the fastest growing areas of 
cosmetic therapies for both men and women. 
Hair follicles are important not only for appearance, 
skin hydration, barrier formation, and protection 
against pathogens but also in wound healing. As hair 
follicles store epidermal stem cells, skin with hair 
follicles heals faster. In addition, bulge stem cells are 
less susceptible to loss through minor trauma and 
damage through ultraviolet light. Thus, treatments 
that involve neogenesis of normal hair follicles would 
find much wider application for restoring normal skin 
function and appearance. 
Methods and compositions capable of generating 
morphologically­correct, fully­developed human hair 
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  Assignee No of patent applications Percentage
  Shiseido Co Ltd   5     7.69%
  Aderans Research Institute Inc   5     7.69%
  Hospital for Sick Children   2     3.08%
  Biointegrence Inc, phoenixbio Co Ltd   2     3.08%
  Follica Inc   2     3.08%
  Organ technologies Inc   2     3.08%
  Universitiy of Jilin   2     3.08%
  University of Southern California   2     3.08%
  National University of Taiwan   2     3.08%
  Aderans Research Institute Inc, Bioamide Inc   1     1.54%
  Agency for science, technology and research   1     1.54%
  Alvi Armani Genomics Inc   1     1.54%
  Anticancer Inc, Li L, Yang M   1     1.54%
  Beijing Yonghe Hair Transplant Technology   1     1.54%
  Biomaster KK   1     1.54%
  Chen B, Gao Q, Zeng Q   1     1.54%
  Chinese Academy of Science Institute of Zoology   1     1.54%
  Total No of patent applications 65 100.00%
  No of Entities 50
Table 1  Owners of hair regeneration patents and patent applications matching all the descriptors 
found in academic literature
Own investigation using patent data base Thomson Innovation.
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follicles, useful for treating conditions such as full­ or 
partial­thickness skin loss, wounds, burns, scars, and 
hair loss have been developed in order to fulfill this 
necessity. In this analysis, only patents aiming to hair 
follicle regeneration or neogenesis have been selected. 
As reviewed, it has been determined that both epi­
thelial cells and mesenchymal cells are essential for 
hair follicle regeneration. The regeneration of chimeric 
hair follicles comprised of mouse DPC and human 
epithelial cells has been shown to be possible, however 
it is still not possible to regenerate completely human 
hair follicles. One of the reasons for this is the difficulty 
to obtain an adequate number of human DPCs having 
the ability to induce hair follicle formation to be used 
for transplantation. Consequently, most of the patents 
filed in this field provide cellular compositions capable 
of hair neogenesis and regeneration or methods for 
isolating progenitor skin cells as well as the culture 
conditions that will allow them to keep their inductive 
properties to promote hair neogenesis or regeneration. 
The first most cited patent listed in Table 2 
(WO1995001423), published in 1995, described a 
method of culturing and modulating subpopulations 
of follicular keratinocytes from upper portions of hair 
follicle to be used for identifying agents which stimulate 
hair growth or prevent hair loss and useful for follicular 
reconstruction and transplantation as well as wound 
coverage in burns and skin ulcer[86] .
In 2005 a patent application (WO2005053763A1) 
developed a method for transplanting the dermal papilla 
or dermal papilla cells and outer skin epidermis tissue or 
epidermal cells to hairless scalp to regenerate hair[94]. 
Different tissue engineered­hair follicle grafts 
were also patented; a scaffold constructed to mimic 
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Figure 2  Evolution of the number of patent applications related to hair regeneration (time frame 1990-2014). Own investigation using patent data base Thomson 
Innovation.
Figure 3  Evolution of accumulated patent families. Tendency line. Own generation based on patent databases.
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the architecture of the native hair follicle and for 
percutaneous implantation facilitating the follicle 
neogenesis process[90] (US20050214344), a hair graft 
comprising plucked hairs having adhered epidermal 
stem cells and follicular dermal cells for implantation 
into wounded skin[105] (US20070122387A1) and a 
hair graft comprising a scaffold, and tissue engineered 
epidermal and dermal layer with hair follicle progenitor 
cells (WO2007062386A2)[98].
Several methods for isolating skin­derived precursor 
stem cells from hair follicles or dermal papillae as well 
as the culture conditions or the delivery into the skin 
of these cells in order to induce hair growth are also 
among the most cited patents (WO2002060396A, 
WO2005071063A1 and US20070092496A1)[88,91,99].
Finally, among the most cited patents are those 
describing methods for isolating hair follicle mesen­
chymal stem cells useful for treating alopecia and 
gene therapy (WO2003104443A2)[89] or useful for hair 
loss, burns or skin replacement as well as for treating 
neurological or degenerative disorders (WO2003­
024406A2)[87].
The rest of the patents analyzed whose content 
is not mentioned, can be found in the References 
section[86­150] at the end of this review. 
CONCLUSION
Although a successful strategy to generate human hair 
follicles from adult cells has not yet been reported, the 
results presented in this review suggest the issues that 
need to be addressed before success can be achieved. 
Perhaps the most important of those issues is to 
provide cells with a three­dimensional structure that 
simulates the natural scaffold. Herein the cells should 
develop and interact among themselves or with other 
cell types in the epithelial­mesenchymal interactions. 
Improving culture conditions that allow the expansion 
of these cells without losing their natural properties, as 
well as selecting the appropriate epithelial stem cells, 
should give us the tools needed to face the challenge 
of regenerating human hair follicles.
These efforts in hair and skin bioengineering are 
also visible in the growing number of patent applications 
filed during the last decade, indicating that this 
technological field is not only attractive to academic 
research but also to the companies that own almost 
half of these patents.
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